Arteriovenous Malformation (AVM)
An arteriovenous malformation (AVM) is an abnormal tangle of blood vessels characterized by direct connections between arteries and veins without an intervening capillary bed, resulting in high-flow shunting of blood that can lead to hemorrhage, seizures, and neurological deficits. 1, 2
Definition and Pathophysiology
AVMs are vascular anomalies defined by:
- Direct arteriovenous shunting (nonnutritive blood flow) between the high-pressure arterial system and low-pressure venous system 1, 3
- Absence of the normal capillary network that typically connects arteries and veins 2, 4
- A central nidus (the abnormal dilated vascular channels where arteriovenous shunting occurs) 1
Epidemiology
- Asymptomatic prevalence on MRI is estimated at 0.05% 1
- Detection rate of symptomatic cases is approximately 1.2 per 100,000 person-years 2
- Typically diagnosed before age 40, though occasionally seen in elderly patients 2
- 10-20% of patients with hereditary hemorrhagic telangiectasia will develop at least one AVM during their lifetime 1
Clinical Presentation
AVMs commonly present with:
Hemorrhage (>50% of cases)
- Intracerebral hemorrhage most common
- Subarachnoid or intraventricular hemorrhage can also occur
- AVM-related hemorrhage accounts for approximately 1% of all strokes 2
Seizures (20-25% of cases)
- Can be focal or generalized
- May indicate the location of the lesion 2
Headaches (15% of patients) 2
Focal neurological deficits (<5% of cases) 2
Other presentations:
Natural History and Risk Assessment
- Annual risk of initial hemorrhage: 2-3% per year for unruptured AVMs 2
- Mortality from first hemorrhage: 10-30% 2
- Long-term disability among survivors: 10-20% 2
- Risk of recurrent hemorrhage is elevated in the first year after initial bleeding:
Risk factors for hemorrhage include:
- Intranidal aneurysm
- Deep venous drainage
- Deep location
- Venous outflow obstruction 1
Diagnostic Imaging
Gold Standard
- Cerebral angiography (arteriography): Provides highest spatial and temporal resolution, critical for characterizing:
Additional Imaging
- MRI: Shows inhomogeneous signal void on T1/T2-weighted sequences, often with hemosiderin suggesting prior hemorrhage 2
- MRA: Provides noninvasive vascular information but lacks detail on intranidal aneurysms and venous drainage 2
- CTA: 90% sensitivity for overall AVM detection, 100% for AVMs >3cm 1
Treatment Approaches
Treatment options include:
Medical management: May be appropriate for unruptured AVMs based on the ARUBA trial, which suggested medical management alone was superior to interventional therapy for preventing death or stroke in unruptured AVMs 1
Surgical resection: Provides immediate obliteration but carries risk of neurological morbidity 5
Endovascular embolization: Minimally invasive but typically achieves cure in only a minority of cases 5, 6
Stereotactic radiosurgery: Minimally invasive with little immediate morbidity, but obliteration occurs in a delayed fashion 5
Combination approaches: Often used for complex AVMs 4
Key Considerations in Management
- Risk-benefit analysis must weigh lifetime hemorrhage risk against intervention risks
- Complete nidal obliteration is the goal of AVM intervention
- Location, size, and vascular architecture influence treatment selection
- For brain AVMs, the recommendation is to obtain both MRI and 4-vessel angiogram to delineate anatomy before treatment planning 2
Complications
- Hemorrhage (most serious complication)
- Progressive neurological deficits
- Seizures
- Hydrocephalus (rare)
- High-output heart failure (in severe cases, especially in young children) 1, 2, 7
AVMs require careful evaluation by an interdisciplinary team of experienced physicians to determine the optimal management strategy that balances the risk of intervention against the natural history of the disease.